Hosted on MSN56m
Number of suspected cases of GBS rises to 170 with 132 confirmed cases: Maharashtra Health Department
The number of suspected cases of Guillain-Barre Syndrome (GBS) in Maharashtra has surged to 170, with 132 confirmed cases, ...
Health and Me on MSN6d
Chemotherapy Can Lead To Nerve Damage Called The Peripheral Neuropathy, Know What It Means
Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...
StudyFinds on MSN2d
Journavx: What to know about new FDA-approved non-opioid pain medication
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The American Journal of Managed Care22h
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Medscape5d
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...